Oruka Therapeutics, Inc. (ORKA) Stock

NASDAQ: ORKAHealthcare company in the biotechnology industry, based in Menlo Park, CA.

Oruka Therapeutics stock price chart

ORKA stock quote & key statistics

Oruka Therapeutics earnings per share

Earnings per share

Oruka Therapeutics revenue & net income

RevenueNet income

Oruka Therapeutics annual financials

Fiscal yearRevenueNet incomeEPS
FY2025$0-$105.4M-$1.86

Fiscal year ending December 31. Source: company filings via EODHD.

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions.

The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Oruka Therapeutics stock FAQ

What is the Oruka Therapeutics stock ticker symbol?

Oruka Therapeutics, Inc. trades on the NASDAQ under the ticker symbol ORKA.

What sector and industry is Oruka Therapeutics in?

Oruka Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.

How many employees does Oruka Therapeutics have?

Oruka Therapeutics, Inc. has about 68 full-time employees.

What were Oruka Therapeutics's revenue and earnings last fiscal year?

Oruka Therapeutics reported revenue of $0 and net income of -$105.4M in fiscal 2025, with earnings per share of -$1.86.

Is Oruka Therapeutics in the Russell 2000?

Yes. Oruka Therapeutics, Inc. (ORKA) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.

When did Oruka Therapeutics go public?

Oruka Therapeutics stock began trading on August 8, 1997.

Russell 2000 Biotechnology stocks

All Russell 2000 →